Abstract The effects of microdialyzing clonidine into the L-7 dorsal horn on the cardiovascular responses, renal sympathetic nerve activity (RSNA), and release of substance P (SP) evoked by static contraction of the triceps surae muscle were studied using anesthetized cats. A microdialysis probe was inserted into the spinal cord ipsilateral to the muscle being contracted or stretched. Contraction, evoked by stimulation of the distal ends of the cut L-7 and S-1 ventral roots for 1 minute, increased mean arterial pressure (MAP), heart rate (HR), and RSNA by 48+6 mm Hg, 18+2 beats per minute, and 66±5%, respectively. Passive stretch of the same muscle for 1 minute also increased MAP, HR, and RSNA by 51±6 contraction. Clonidine (380 ,umol/L) did not alter the release of SP in the dorsal horn during contraction (before clonidine, 0.380+0.018 fmol/100 ,uL; after clonidine, 0.356±0.012 fmol/ 100 ,uL). These results demonstrate that stimulation of a2-adrenergic receptors in the L-7 dorsal horn attenuates the cardiovascular responses and RSNA changes to static contraction and passive stretch. This attenuation by clonidine appears not to be mediated through presynaptic inhibition of SP release. (Circ Res. 1994;75:567-575.) Key Words * exercise pressor reflex * passive stretchsympathetic nerve activity * a2-adrenergic receptor .
19±4 mm Hg, 7±1 beats per minute, and 24+5%, respec- tively. The increases elicited by passive stretch were also attenuated (MAP, Key Words * exercise pressor reflex * passive stretchsympathetic nerve activity * a2-adrenergic receptor .
yohimbine Static muscle contraction evokes increases in arterial pressure (AP), heart rate (HR), cardiac contractility, and renal sympathetic nerve activity (RSNA) in anesthetized cats.1-6 These changes are a reflex arising from the contracting muscle, which is commonly known as the "exercise pressor reflex."4 The reflex cardiovascular and sympathetic nerve activity responses are initiated by a contraction-induced activation of thinly myelinated (group III) and unmyelinated (group IV) muscle afferents. The majority of the group III afferents display mechanosensitivity; ie, their endings respond to mechanical stimuli, whereas the majority of the group IV afferents respond to metabolic changes. 7, 8 The dorsal horn of the spinal cord is the site of the first synapse of the majority of group III and group IV muscle afferents.9'10 Thus, this region may play an important role in the reflex cardiovascular changes observed during muscle contraction. A variety of neurotransmitters and/or neuromodulators of group III and group IV afferents have been identified in the dorsal horn, substance P (SP) being an example.1"-"4 In addition, it has been recently reported that static muscle contraction causes the release of SP in the dorsal horn region of the spinal cord and that this release is related to the developed tension.15 '16 Autoradiographic studies have identified significant levels of a2-adrenergic receptors in the dorsal horn.17 ' to the standards and the samples. These were incubated for 24 hours at 4°C. Wells were then washed three times with RIA buffer, separated, and counted for 10 minutes in a 20-well gamma counter; a cubic spline algorithm was used for data processing.
The cross-reactivity at IC50 was 100% for SP-(1-11) and SP-(2-11); 98% for 125[Tyr8]SP; 95% for SP-(1-9); 85% for SP-(1-7); 75% for SP-(3-11); 60% for SP-(1-6); 45% for SP-(1-4); 12% for SP-(4-11) and SP-(5-11); 5% for SP-(6-11); and <0.01% for SP-(7-11), SP-(8-11), SP-(9-11), neurokinin A, neurokinin B, somatostatin, neuropeptide K, kassinin, eledoisin, and physalaemin. The detection limit of the assay was 0.07 finol/100 ,uL, and the coefficients of variation for 0.1 fmol/100 pL and 0.5 fmol/100 gL were 6.3% and 2.1%, respectively.
Histology
At the end of all the experiments, the probe was perfused with a solution containing ferric chloride for 40 minutes, followed by another 10-minute dialysis of distilled water to minimize accumulation of ferric chloride at the site of the probe insertion. The animal was euthanized with an intravenous injection of sodium pentobarbital (120 mg/kg). The L-5-S-2 region of the spinal cord was removed and placed in a solution of 10% phosphate-buffered formalin with 1% potassium ferrocyanide and potassium ferricyanide to elicit a Prussian blue reaction. On a separate day, 50-,um frozen transverse sections of the spinal cord were cut using a cryostat (2800 Frigocut E, Reichert-Young, Cambridge Instruments) to determine the location of the tract and the distribution of the Prussian blue reaction.
Experiment 1 (Protocol)
Eighteen cats were used in this protocol. The preparation was allowed to stabilize for 2 hours, during which the ECF was continuously dialyzed. Then, a static contraction of the right triceps surae muscle was performed, and AP, mean arterial pressure (MAP), HR, RSNA, and muscle tension were recorded. The contraction was induced by simultaneous electrical stimulation (three times motor threshold, 40 Hz, 0.1 millisecond) of the peripheral cut ends of the L-7 and S-1 ventral roots for 1 minute. After measuring these control cardiovascular responses, the dose-response effect of microdialyzing clonidine was determined. This was done by perfusing clonidine at doses of 3.8 .Lmol/L, 38 ,mol/L, 380 lrmolIL, and 30 Hz, 0.1 millisecond duration) during a 10-minute collection period ( Table 1 ). The alternate stimulation-evoked contraction was performed so that the muscle did not fatigue rapidly. Next, the muscle was allowed to recover during a 40-minute (two times for 20 minutes each) collection period. The muscle contraction was then repeated during another 10-minute collection. After this, another 40-minute (two times for 20 minutes each) collection period was performed. The dialysates from the two contractions were then combined so that the final sample volume was 100 ttL. Then, clonidine (380 ,uL) was microdialyzed for 40 minutes (two collection periods for 20 minutes each), and the contraction protocol was repeated as described above. The MAP and HR responses to the muscle contractions before and after clonidine were also recorded during this protocol. The samples were stored in a freezer (-80°C), and on a separate day, the SP-like immunoreactivity (SP-LI) of the perfusate was measured by RIA (see above). The tubes containing the dialysis samples were coded, and the person who performed the assays was unaware of the code or the protocol.
Data Analysis
Data were continuously recorded on an eight-channel chart recorder (Gould model 2800S). The carotid artery catheter was connected to a pressure transducer (Statham model P231D) for measuring AP. MAP was obtained by integrating the AP signal with a time constant of 4 seconds. HR was derived from the AP pulse (Biotach, Gould). Muscle tension was measured by the force transducer.
A 60-second period of RSNA (cRSNA, in microvolts) was measured before each muscle manipulation. Since the absolute voltage (in microvolts) of RSNA varied between animals, the precontraction and prestretch control values were defined as 100%. Percent change in RSNA (RSNA%) from control values during each muscle manipulation were calculated by using the following formula:
Data are expressed as mean+SEM. A one-way ANOVA with repeated measures (RM-ANOVA) was used to compare the dose-response effect of clonidine. Peak changes in MAP, HR, and RSNA elicited by muscle contraction before and 40 minutes after clonidine administration were compared by paired Student's t test. The same comparisons were performed for the responses evoked by passive stretch. The hemodynamic, RSNA, and tension data were analyzed by one-way RM-ANOVA. Comparisons of changes in cardiovascular variables and RSNA measured before, 40 minutes after clonidine, and 2 hours after discontinuation of clonidine (recovery) were performed by one-way RM-ANOVA. Also, the one-way RM-ANOVA was used for comparison of changes in MAP, HR, and RSNA before yohimbine, after yohimbine, and after clonidine. Basal and peak changes in SP-LI elicited by muscle contraction before and after clonidine were compared by one-way RM-ANOVA. The cardiovascular variables measured in experiment 2 were also analyzed by paired Student's t test. Post hoc analyses for the ANOVAs were performed by Tukey's test.26 For all analyses, P<.05 was considered to be statistically significant.
Results

Experiment 1
Dose-Response Effect of Clonidine
The muscle contraction elicited an increase in MAP, which was attenuated by microdialysis of clonidine in a dose-dependent manner (Fig 1) 
Muscle Contraction Before and After
Clonidine (380 pmnolIL)
The tracings of the changes in AP, MAP, HR, RSNA, and tension during a static muscle contraction evoked after 2 hours of microdialysis of the ECF (control) and 40 minutes of clonidine (380 gmol/L) in the same cat are shown in Fig 2. During the control condition, contraction caused increases in MAP, HR, and RSNA. After clonidine, these contraction-evoked responses were attenuated. The peak tensions developed by the contracting muscle before and after clonidine were the same. The peak changes in MAP and RSNA in response to muscle contraction before and 40 minutes after microdialysis of clonidine are shown in Fig 3A. The baseline and peak cardiovascular variables, RSNA values, and tension data in response to muscle contraction before and after microdialysis of clonidine are given in Table 2 . The typical tracings of changes in the AP, MAP, HR, RSNA, and tension evoked by passive stretch of the triceps surae muscle before (control) and 40 minutes after clonidine (380 ,umol/L) in the same cat are illustrated in Fig 4. Passive stretch produced an increase in MAP, HR, and RSNA, whereas after microdialysis of clonidine, these responses were blunted. The peak tensions before and after clonidine were the same. The peak increases in MAP and RSNA in response to stretch under control conditions and after 40 minutes of microdialyzing clonidine are shown in Fig 3B. The baseline and peak cardiovascular variables, RSNA values, and tension data in response to passive stretch before and after microdialyzing clonidine are shown in Table 2 . Muscle Contraction and Passive Stretch During Recovery For the six cats in which recovery was tested, clonidine blunted the MAP and RSNA responses to muscle contraction; however, after 2 hours of microdialyzing ECF, the responses recovered (Fig SA) . This indicates that the clonidine-induced attenuation of the pressor and RSNA responses were due to the effects of the drug. The increases in MAP and RSNA in response to passive stretch also recovered (Fig 5B) . Likewise, the peak changes in HR to both contraction and stretch recovered. For contraction, the HR changes in the control condition, during clonidine administration, and in recovery were 19+2, 7+2, and 20+3 beats per minute, respectively; for stretch, the changes were 18+2, 7+2 and 19±2 beats per minute, respectively. Peak tensions were the same throughout the protocol.
Effects of Yohimbine on Muscle Contraction and Passive Stretch
Yohimbine had no effect on baseline MAP, HR, and RSNA (n=5). Moreover The basal release of SP-LI for this preparation (Fig 7) is similar to that shown in a previous study. 16 During the control condition, muscle contraction evoked an increase in the concentration of SP-LI. The basal release of SP was increased during the dialysis of clonidine. Subsequent muscle contraction also elicited an increase in SP-LI, which was not different from that before clonidine (Fig 7) . The tensions developed by the contracting muscle before and after clonidine were the same. The peak changes in MAP and HR in response to muscle contraction before microdialysis of clonidine were 32±3 mm Hg and 14+1 beats per minute, respectively, whereas after clonidine, the MAP and HR responses were 14+2 mm Hg and 9+1 beats per minute, respectively (P<.05 versus values before clonidine).
Histology
Sections of the spinal cord, viewed with a microscope, revealed the Prussian blue reaction in the dorsal horn (Fig 8) . The tract made by the microdialysis probe was seen entering through the L-7 dorsal horn to a depth of '-3 mm. The tip of the probe was at the level of the lamina VII. The rostral-caudal spread of the blue reaction was :'4 mm. It was not possible to obtain histological data for the spinal cords of five cats because of technical difficulties. However, the cardiovascular and RSNA responses to muscle contraction in these experiments were similar to those in the others. Thus, these data were not excluded. 
Discussion
The present study determined the effects of clonidine, microdialyzed into the L-7 dorsal horn, on the reflex increases in MAP, HR, and RSNA in response to static contraction and passive stretch of the triceps surae muscle. In the present study, clonidine attenuated the reflex increases in MAP, HR, and RSNA to muscular contraction and passive stretch. The attenuations by clonidine were blocked by prior microdialysis of yohimbine, the a2-adrenergic receptor antagonist. These results demonstrate that stimulation of a2-adrenergic receptors in the L-7 dorsal horn of the spinal cord attenuates the cardiovascular and RSNA changes to static muscle contraction and passive stretch. In addition, clonidine did not change the release of SP in the dorsal horn in response to muscle contraction. There-A. CONTRACTION fore, these data do not support the hypothesis that clonidine attenuates the cardiovascular responses to muscle contraction through an inhibition of the release of SP in the dorsal horn of the spinal cord.
Autoradiographic visualization of the rat and cat spinal cord sections has demonstrated a dense distribution of a2-adrenergic receptor binding sites in the dorsal horn.17,18 Microinjection of norepinephrine into the dorsal horn of the cat spinal cord produces an inhibition of C-fiber (ie, group IV afferent) reflexes evoked by either electrical stimulation of a cutaneous nerve or noxious radiant heat applied to the foot pad.19 Furthermore, iontophoretically applied norepinephrine suppresses dorsal horn neuronal activity evoked by noxious stimuli.21,27 It has also been reported that administration of norepinephrine into the dorsal horn neurons B. PASSIVE STRETCH The activation of group III and group IV muscle afferents arising from the contracting muscle has been shown to involve the afferent arm of the reflex cardiovascular changes to static contraction.2,4 The dorsal horn is the site of the first synapse of the majority of the group III and group IV muscle fibers; after reaching the first synapse, impulses evoked by activation of these afferents are transmitted through the second-order neurons in the dorsal horn to higher brain centers.9 10,28 A previous report has shown that the intrathecal administration of clonidine ilnto the lumbosacral spinal cord attenuates the cardiovascular responses to muscle contraction through stimulation of a2-adrenergic receptors in the spinal cord. 23 However, a more localized site of action of clonidine in the spinal cord has not been investigated. In the present study, all the dorsal roots of the spinal cord from L-5 to S-2, excluding L-7, were severed. Thus, the contraction-or stretch-induced activation of the group III and group IV muscle afferents was transmitted only through the L-7 dorsal root. The distribution of the Prussian blue reaction in the L-7 dorsal horn region, extending =4 mm rostrocaudally, It has been reported that passive stretch of the triceps surae muscle evokes reflex cardiovascular responses through stimulation of mechanosensitive muscle afferents.83031 In the present study, passive stretch evoked increases in the cardiovascular and RSNA responses, which were attenuated after microdialyzing clonidine. This suggests that clonidine modulates the mechanosensitive muscle afferents through an action on the a2-adrenergic receptors in the L-7 dorsal horn region of the spinal cord. Clonidine also blunted the cardiovascular and RSNA responses to muscle contraction, which activates both mechanoreceptors and metaboreceptors. However, clonidine attenuated the pressor responses to contraction and stretch by equivalent amounts. Because there is no specific stimulus to activate the metabosensitive afferents only, it cannot be concluded from the present study that clonidine does not act on metabosensitive muscle afferents.
Microdialysis of yohimbine into the L-7 dorsal horn did not alter the baseline cardiovascular variables and RSNA. Furthermore, yohimbine had no influence on the reflex MAP, HR, and RSNA responses to contraction and stretch. Therefore, a2-adrenergic receptors in Although the contraction-evoked release of SP was not decreased statisticallv (P-=.064) bv clonidine. there was a tendency for it to go down. The release of SP in response to muscle contraction during clonidine administration was 0.024 fmol/100 gL less than the preclonidine value. Although these values seem quite small, this mav represent a functionallx important reduction. Since microdialvsis was designed to sample the interstitial fluid. and thereby quantifv neurotransmitter release, a 0.024 fmol (400 000 molecules) reduction in SP may play a role in the physiological effect of clonidine. Depending on the number of svnapses involved, a decrease in the release of 400 000 molecules of SP mav have been the mechanism bv which clonidine blunted the reflex responses to muscle contraction. However, the number of synapses from which the microdialysis probe samples is unknown. Further. the relation between the quantitv of neurotransmitter release and effector response is unknown. Thus. the potential functional implication for the small decrease in the contraction-evoked release of SP bsx clonidine is unclear.
Although the results fail to indicate that clonidine reduces the contraction-induced release of SP, a presynaptic mediated effect of clonidine cannot be excluded. because a>-adrenergic receptor activation may haxre altered the release of other neurotransmitters/ neuromodulators in the dorsal horn involved in the reflex cardiovascular changes to muscle contraction. Somatostatin is a neurotransmitter and/or neuromodulator found in the afferents svnapsing in the dorsal horn." ' Wilson et a1' demonstrated that the spinal release of somatostatin plavs a role in eliciting the cardiovascular responses to isometric muscle contraction. Thus, it may he possible that the attenuating effects of clonidine could haxe been mediated through a presvnaptic inhibition of the release of somatostatin (or other neurotransmitters/ neuromodulators) in the dorsal horn of the spinal cord.
In conclusion, the present studv demonstrated that the reflex cardiovascular and RSNA changes evoked bv both stimulation-induced muscle contraction and passive stretch were attenuated by the a -adrenergic receptor agonist clonidine microdialxzed into the L-7 dorsal horn of the spinal cord. Bv use of microdialvsis. the site of action of clonidine was presumed to be localized to the L-7 dorsal horn. The attenuation produced by clonidine appears not to be mediated through a reduction in the release of SP in the dorsal horn of the spinal cord.
